Table 3.
Summary Statistics for body composition measures and lipid parameters at baseline and at 3-month follow-up after initiation of BAT.
| Baseline, mean (sd) | 3-month follow-up, mean (sd) | % of ↑/↓ from baseline to 3-month follow-up | % change from baseline to 3-month follow-up, mean (sd) | P value for difference* | |
|---|---|---|---|---|---|
|
| |||||
| Subcutaneous fat area, cm2 | 265.1 (98.3) | 245.0 (96.0) | 83 ↓ | ↓ 7.8 (8.2) | <0.001 |
| Visceral fat area, cm2 | 233.1 (119.1) | 212.5 (121.8) | 68 ↓ | ↓ 9.8 (18.2) | 0.001 |
| Muscle area, cm2 | 140.4 (24.4)) | 157.5 (27.8) | 97 ↑ | ↑ 12.2 (6.7) | <0.001 |
| LDL, mg/dL | 102.4 (35.5) | 91.6 (31.2) | 74 ↓ | ↓ 12.4 (19.1) | <0.001 |
| HDL, mg/dL | 59.0 (20.1) | 49.7 (13.5) | 84 ↓ | ↓ 9.1 (11.4) | <0.001 |
| TGs, mg/dL | 146.9 (73.8) | 121.3 (71.9) | 69 ↓ | ↓ 26.9 (59.2) | 0.0005 |
| FACIT-F scale | 39.3 (10.5) | 42 (9.6) | 52 ↑ | ↑ 2.11 (12.6) | 0.33 |
| Energy | 56.1 (21.1) | 64.1 (24.7) | 63 ↑ | ↑ 7.8 (19.5) | 0.004 |
| Physical functioning | 66.0 (22.3) | 70.9 (21.8) | 54 ↑ | ↑ 4.2 (15.5) | 0.05 |
| Emotional well being | 81.2 (12.3) | 84.4 (13.2) | 54 ↑ | ↑ 1.8 (8.6) | 0.09 |
| Limitations due to physical health | 56.5 (43.7) | 73.4 (36.3) | 38 ↑ | ↑ 13.9 (32.2) | <0.001 |
*
P values were testing the differences of outcome’s distribution between baseline and 3-month follow-up after BAT therapy via Wilcoxon signed-rank test.